Vai al contenuto principale della pagina

Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Organization World Health Visualizza persona
Titolo: Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance Visualizza cluster
Pubblicazione: Geneva, : World Health Organization, 2014
Descrizione fisica: 1 online resource (254 p.)
Disciplina: 616
Soggetto topico: Drug resistance -- Periodicals
Drug resistance in microorganisms
Drug resistance
Anti-infective agents - Classification
Drug resistance in microorganisms - Effect of drugs on
Risk management
Risk
Risk Management
Information Science
Drug Resistance
Microbiological Phenomena
Epidemiologic Measurements
Therapeutic Uses
Probability
Pharmacologic Actions
Pharmacological Phenomena
Public Health
Organization and Administration
Statistics as Topic
Health Services Administration
Environment and Public Health
Chemical Actions and Uses
Physiological Phenomena
Health Care Evaluation Mechanisms
Health Care
Epidemiologic Methods
Drug Therapy
Quality of Health Care
Investigative Techniques
Diagnostic Techniques and Procedures
Health Care Quality, Access, and Evaluation
Anti-Infective Agents
Classification
Risk Assessment
Drug Resistance, Microbial
Biology
Health & Biological Sciences
Microbiology & Immunology
Soggetto genere / forma: Publication Formats
Technical Report
Persona (resp. second.): World Health Organization
Note generali: Description based upon print version of record.
Nota di contenuto: Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References
SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment
4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses
4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine
5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material
Sommario/riassunto: This WHO report produced in collaboration withMember States and other partners provides as accuratea picture as is presently possible of the magnitude ofAMR and the current state of surveillance globally.The report focuses on antibacterial resistance (ABR)in common bacterial pathogens. Why? There is amajor gap in knowledge about the magnitude of thisproblem and such information is needed to guideurgent public health actions. ABR is complex andmultidimensional. It involves a range of resistancemechanisms affecting an ever-widening range ofbacteria most of which can cause a wide spectrumof disea
Titolo autorizzato: Antimicrobial Resistance. Global Report on Surveillance  Visualizza cluster
ISBN: 92-4-069266-5
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910825162403321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui